Literature DB >> 7927641

Peptide receptors in astroglia: focus on angiotensin II and atrial natriuretic peptide.

C Sumners1, W Tang, W Paulding, M K Raizada.   

Abstract

Astroglial cells derived from the mammalian central nervous system contain a wide variety of peptide receptors, including specific sites for angiotensin II (AII) and atrial natriuretic peptide (ANP). The AII receptors present in these cells are primarily of the AT1 subtype. The ANP receptors present in these cells consist of a mix of ANP-A and ANP-B sites ("biological receptors") and also ANP-C sites ("clearance receptors"). Available evidence indicates that activation of AII receptors results in a stimulation of astroglial proliferation, whereas ANP has an antiproliferative effect in these cells. Intracellular pathways which may mediate these effects of AII and ANP on cell proliferation are discussed, including the presentation of novel data on the activation of protein kinase C and of glucose uptake by AII. We also consider the possibility that the opposing actions of AII and ANP on astroglial proliferation may represent another facet of the mutual antagonism between these two peptides, which has been observed throughout mammalian systems.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7927641     DOI: 10.1002/glia.440110206

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  10 in total

Review 1.  Astrocytes and the Renin Angiotensin System: Relevance in Disease Pathogenesis.

Authors:  Ann Tenneil O'Connor; Michelle A Clark
Journal:  Neurochem Res       Date:  2018-06-01       Impact factor: 3.996

Review 2.  Physiology of Astroglia.

Authors:  Alexei Verkhratsky; Maiken Nedergaard
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

3.  Angiotensin receptor type 1 blockade in astroglia decreases hypoxia-induced cell damage and TNF alpha release.

Authors:  Lusine Danielyan; Ali Lourhmati; Stephan Verleysdonk; Daniela Kabisch; Barbara Proksch; Ulrike Thiess; Sumaira Umbreen; Boris Schmidt; Christoph H Gleiter
Journal:  Neurochem Res       Date:  2007-04-04       Impact factor: 3.996

4.  Histamine H1 receptor activation stimulates mitogenesis in human astrocytoma U373 MG cells.

Authors:  A Hernández-Angeles; L E Soria-Jasso; A Ortega; J A Arias-Montaño
Journal:  J Neurooncol       Date:  2001-11       Impact factor: 4.130

Review 5.  Role of neurons and glia in the CNS actions of the renin-angiotensin system in cardiovascular control.

Authors:  Annette D de Kloet; Meng Liu; Vermalí Rodríguez; Eric G Krause; Colin Sumners
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-06-17       Impact factor: 3.619

6.  Astrocytes Contribute to Angiotensin II Stimulation of Hypothalamic Neuronal Activity and Sympathetic Outflow.

Authors:  Javier E Stern; Sookjin Son; Vinicia C Biancardi; Hong Zheng; Neeru Sharma; Kaushik P Patel
Journal:  Hypertension       Date:  2016-10-03       Impact factor: 10.190

7.  The effect of angiotensin II and IV on ERK1/2 and CREB signalling in cultured rat astroglial cells.

Authors:  Adam Holownia; Jan J Braszko
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-10-19       Impact factor: 3.000

Review 8.  Physiology of Astroglia.

Authors:  Alexei Verkhratsky; Vladimir Parpura; Nina Vardjan; Robert Zorec
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

9.  Angiotensin II Type 1 Receptor Blockers Inhibit KAT II Activity in the Brain-Its Possible Clinical Applications.

Authors:  Izabela Zakrocka; Katarzyna M Targowska-Duda; Artur Wnorowski; Tomasz Kocki; Krzysztof Jóźwiak; Waldemar A Turski
Journal:  Neurotox Res       Date:  2017-07-21       Impact factor: 3.911

10.  Immunohistochemical Localization of AT1a, AT1b, and AT2 Angiotensin II Receptor Subtypes in the Rat Adrenal, Pituitary, and Brain with a Perspective Commentary.

Authors:  Courtney Premer; Courtney Lamondin; Ann Mitzey; Robert C Speth; Mark S Brownfield
Journal:  Int J Hypertens       Date:  2013-03-19       Impact factor: 2.420

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.